Skip to content

Clinical trials

Completed Observational Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Observational Status: Completed Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20051
20065
20073
20084
20098
20108
20114
20124
20134
20142
20152
20162
20181
20191
20202
20213
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan20
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
Alcon Research3
National Eye Institute (NEI)3
St. Erik Eye Hospital2
University Hospital, Basel, Switzerland2
University of Colorado, Denver2
Acer Medical Inc.1
Allergan S.A. DE C.V..1
Aristotle University Of Thessaloniki1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension66
Glaucoma, Open-Angle38
Glaucoma35
Exfoliation Syndrome4
Low Tension Glaucoma3
Aniridia1
Blindness1
Cataract1
Central Serous Chorioretinopathy1
Congenital Abnormalities1

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.